ValuEngine upgraded shares of Retractable Technologies, Inc. (NYSEMKT:RVP) from a sell rating to a hold rating in a report issued on Monday.

Retractable Technologies (RVP) opened at 0.615 on Monday. The company has a 50-day moving average of $0.66 and a 200-day moving average of $1.01. Retractable Technologies has a 52 week low of $0.54 and a 52 week high of $2.74. The firm’s market cap is $19.47 million.

Retractable Technologies (NYSEMKT:RVP) last announced its quarterly earnings data on Monday, August 14th. The company reported ($0.05) EPS for the quarter. The company had revenue of $7.65 million during the quarter. Retractable Technologies had a negative return on equity of 22.24% and a negative net margin of 17.65%. Equities research analysts forecast that Retractable Technologies will post ($0.46) earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Retractable Technologies, Inc. (RVP) Raised to Hold at ValuEngine” was originally reported by Marea Informative and is the property of of Marea Informative. If you are viewing this report on another website, it was copied illegally and republished in violation of international trademark and copyright laws. The legal version of this report can be read at http://www.mareainformativa.com/retractable-technologies-inc-rvp-raised-to-hold-at-valuengine/116599/.

In related news, insider Thomas J. Shaw acquired 1,000,000 shares of the stock in a transaction on Wednesday, August 23rd. The shares were acquired at an average price of $0.57 per share, with a total value of $570,000.00. Following the completion of the transaction, the insider now owns 13,065,642 shares in the company, valued at approximately $7,447,415.94. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

A hedge fund recently raised its stake in Retractable Technologies stock. WealthTrust Axiom LLC raised its holdings in Retractable Technologies, Inc. (NYSEMKT:RVP) by 6.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 583,062 shares of the company’s stock after purchasing an additional 36,898 shares during the period. WealthTrust Axiom LLC owned 1.84% of Retractable Technologies worth $740,000 at the end of the most recent reporting period.

About Retractable Technologies

Retractable Technologies, Inc designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Stock Ratings for Retractable Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies Inc. and related stocks with our FREE daily email newsletter.